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Abstract
Background and aims: Among urine pathogens, Escherichia coli (E. coli) causes 80% of urinary tract infections (UTIs). Due to the destructive 
nature of penicillins, cephalosporins and carbapenems (except for monobactam such as aztreonam) and carbapenemase enzymes 
have created many problems for treating infectious diseases.  Therefore, this study aimed to investigate the phenotypic and molecular 
characterization of metallo-beta-lactamase (MBL) genes produced by E. coli isolates in an educational hospital during 2016-2017.
Methods: This cross-sectional study investigated 80 UTI samples affected by E. coli. In addition, antibiotic susceptibility was evaluated 
by disk diffusion and E-test methods for two antibiotics of meropenem and imipenem. Phenotypic tests containing modified Hodge 
test,  ethylenediaminetetraacetic acid (EDTA) disk synergy test, and AmpC Disk were performed to identify MBL enzyme-producing 
strains. Finally, the frequency of Verona integron-encoded metallo-β-lactamase (VIM) and imipenemase (IMP) genes was determined by 
polymerase chain reaction (PCR).
Results: Among 80 E. coli samples, 21 (26.25%) isolates were resistant to meropenem and imipenem as detected by the disk-diffusion 
method and E-test. Further, phenotypic tests including modified Hodge test, EDS test, and AmpC disk test showed the positivity of 15 
 (18.75%), 15 (18.75%), and 8 (10%) isolates, respectively (P < 0.001). Eventually, polymerase chain reaction (PCR) test results for the VIM 
gene showed 19 (23.75%) positive  isolates of E. coli, but the IMP gene was observed in none of the isolates (P < 0.001).
Conclusion: In general, the emergence of E. coli producing MBL enzymes is a serious threat among clinical infections. The findings of 
this study indicated the presence of E. coli producing MBL. These enzymes can degrade carbapenems antibiotics, the last class current 
treatment of multiple drug-resistance infections.
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Introduction 
The family of Enterobacteriaceae, especially Escherichia 
coli, causes urinary tract infections (UTIs) (1). UTI is one 
of the most important factors in renal scarring, kidney 
tissue damage, kidney failure, poor growth, kidney stones, 
and hypertension (2-4). Almost 30%-40% of UTI are 
nosocomial infections which are considered as the most 
significant cause of sepsis in hospitalized patients (5). E. 
coli in the Enterobacteriaceae family causes hospital and 
acquired infections more than the other members of 
its family (6). In addition, E. coli is the most common 
etiologic agent of the UTI accounting for 80% of cases 
(7). Resistance to antibiotic therapy in patients with 
UTIs represents an example of the increasing problem 
of antimicrobial resistance (8). This type of resistance 
has always been a major problem for human health (9) 
and affects patients in general hospitals worldwide (10). 
Carbapenem antibiotics family consists of ertapenem, 
imipenem, doripenem, and meropenem. Nowadays, 
because of the broad spectrum and non-hydrolysis by 
beta-lactamases enzymes, this family has become the most 
important selected drug for treating serious infections in 
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Enterobacteriaceae resistance to multiple drugs that produce 
extended broad-spectrum β-lactamases (ESBLs) (11-13). 
Carbapenemase is an important mechanism of resistance 
to carbapenem antibiotics. Further, resistance by metallo-
beta-lactamases (MBLs) often relies on the plasmid (14,15). 
According to ambler classification, carbapenemase belongs 
to molecular classes A, B, and D. Class A carbapenemase 
includes Guiana-extended-spectrum, imipenem-
hydrolysingβ-lactamase, Serratia marcescens enzyme, and 
Klebsiella pneumonia carbapenemase (KPC) enzymes that 
can be inhibited by varying degrees of clavulanate and 
they hydrolyse penicillins and cephalosporins more than 
carbapenems. Some of them, including KPC, lack the 
strong carbapenemase ability, which might be considered 
as ESBLs. Furthermore, carbapenemase class B is an MBL 
that is considered as group B of amblers based on the 
similarity of their amino acid sequences. Moreover, it can 
be classified into group 3 (Bush’s classification) based on 
the structure of the substrate and the inhibitor component. 
MBL activity depends on zinc metal, which is capable of 
hydrolyzing beta-lactam antibiotics and all carbapenems 
except for aztreonam. MBLs are resistant to beta-lactamase 
inhibitors but can be prevented by chelating agents such 
as ethylenediaminetetraacetic acid (EDTA). According to 
molecular structures, MBLs are divided into 6 categories 
of Verona integron-encoded metallo-β-lactamase (VIM), 
imipenemase (IMP), German imipenemase, Seoul 
imipenemase (SIM), São Paulo metallo-beta-lactamase, 
and Adelaide imipenemase. The VIM, IMP, and SMP-1 
were identified in Pseudomonas aeruginosa, Acinetobacter 
baumannii, and other members of the Enterobacteriaceae 
family (16-20). Considering the above-mentioned 
explanations, the aim of this study was to determine the 
frequency of VIM and IMP genes and MBL enzymes in 
E. coli isolates by molecular and phenotypic methods in 
educational hospitals of Shahrekord, Iran.
Materials and Methods
Bacterial Isolates
In this study, 80 E. coli isolates of UTI patients were 
prepared in several sections of the university hospital (e.g., 
urology, women, internal, intensive care unit) from May to 
October 2016. These patients were infected by UTI within 
48-72 hours after hospitalization and the primary urine 
cultures were negative for them. 
Antimicrobial susceptibility testing and minimum 
inhibitory concentration (MIC)
First, the samples were cultured on blood agar and eosin-
methylene-blue mediums (Himedia) and then different 
biochemical identifier tests such as Triple sugar iron 
agar, Simon citrate, methyl red/Voges-Proskauer, SIM, 
and oxidase were performed on the isolates. In addition, 
antibiotic susceptibility was determined by the disk 
diffusion method (Kerby-Bauer) for meropenem and 
imipenem (Mast) and the plates were incubated for 18-24 
hours at 37°C. Finally, the Epsilon test (E-test) was used 
(Liofilchem Company) for two antibiotics of meropenem 
and imipenem on the Mueller-Hinton agar culture medium 
in order to determine the MIC.
Phenotypic diagnosis of MBLs
Phenotypic tests such as the modified Hodge test (MHT), 
EDTA disk synergy test (EDS), and AmpC disk test were 
performed to detect the strains containing MBL enzymes. 
Further, E. coli ATCC 25922 and Klebsiella pneumonia 
ATCC 1705 were considered as negative and positive 
controls for running MHT, respectively. Furthermore, 
bacterial suspension equivalent to 0.5 McFarland was 
prepared from the fresh cultures of E. coli ATCC 25922 and 
then diluted in a 1:10 ratio and passaged on Mueller-Hinton 
agar. The plates were maintained at 37°C overnight. The 
appeared clover leaf shape in the inhibition site of bacterial 
growth resulted from the production of carbapenemase 
by the tested bacteria strain (21-23). Moreover, 0.5 molar 
EDTA solution and meropenem disk were used in the EDS 
test, followed by passaging sample suspensions equivalent 
to 0.5 McFarland on Mueller-Hinton agar. A meropenem 
(10 μg) disk was placed on the plate and then 10 mL of 
0.5 molar EDTA solution was added to a blank disk (filter 
paper with a diameter of 6 mm) in an aseptic condition. 
Additionally, the blank disk was put at a 10 mm distance of 
the meropenem disk and incubated overnight at 37°C. The 
increased growth inhibition zone between the two disks was 
the indicator of MBL positive bacteria (21,22). In addition, 
the AmpC disk test method was used to recognize beta-
lactamase AmpC. Next, 0.5 McFarland suspension of E. 
coli ATCC 25922 on the Mueller-Hinton culture medium 
was passaged and a cefoxitin disk (30 μg) was placed on the 
plate near a blank disk (Whatman paper) that was exposed 
to normal saline. Then, colonies resistant to meropenem 
were inoculated in the blank disk. A positive result for 
the production of AmpC β-lactamase was based on the 
observation of a dentin in the growth area of the cefoxitin 
disk in the vicinity of the blank disk (21-23).
Determination of MBL genes
The positive isolates for carbapenemase enzymes were used 
to investigate VIM and IMP genes by the polymerase chain 
reaction (PCR). Hence, their DNA concentrates were 
extracted by boiling. In the boiling process, 1 mL of sterile 
distilled water was poured in a 1.5 mL microtube. Then, 4-5 
fresh bacterial colonies were dissolved and the microtube 
was placed on a heated plate at 95°C for 15 minutes to 
boil. Next, the samples were centrifuged at 14000 rpm for 
5 minutes and the transparent liquid containing bacterial 
DNA was removed for PCR. In this study, Acinetobacter 
baumannii AC54/97 and Pseudomonas aeruginosa PO510 
were a positive control for IMP and VIM genes (24). 
Further, 16srRNA was considered as internal control (25). 
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The primers used for VIM and IMP genes were designed 
by Oligo 7 software (Table 1).
Statistical analysis
Descriptive statistics (i.e., frequency, percentage, mean, 
and standard deviation) and inferential statistics (Fisher’s 
exact test) were analyzed and P < 0.05 was considered as the 
significance level.
Results
In the disk diffusion method, 21 isolates of E. coli were 
resistant and 5 isolates were intermediate for meropenem 
and imipenem. Furthermore, 21 isolates of E. coli were 
resistant (MIC ≥ 4 μg/mL) to meropenem and imipenem 
antibiotics in the E-test.
Modified Hodge test 
Resistant strains to meropenem and imipenem by E-test 
were used in MHT to detect carbapenemase enzymes and 
15 (18.75%) isolates of E. coli were positive (P < 0.001). 
Figure 1 shows the positive and negative samples by MHT.
EDTA disk synergy test
Escherichia coli isolates resistant to carbapenemase antibiotics 
were used in the EDS test to produce carbapenemase 
enzymes. In this test, 15 (18.75%) isolates were positive 
(P < 0.001). Figure 2 illustrates two separate plates (1 & 2) 
that are side by side and considered as negative and positive 
isolates for the EDS test, respectively.
AmpC disk test
The presence of a notch in the side of the disk reflects the 
production of AmpC β-lactamase by E. coli, which is on the 
blank disk (Figure 3, AmpC positive). In this test, 8 isolates 
(10%) of E. coli were AmpC beta-lactamase (P < 0.001). 
Table 2 presents the results of phenotypic tests for detecting 
carbapenemase enzymes.
The results were similar for disk diffusion and E-Test. 
Moreover, among the tests for detecting carbapenemases 
enzymes, the MHT and EDS demonstrated the same 
results, while their results differed from that of the AmpC 
test.
Polymerase chain reaction
The electrophoresis technique was performed on the 8% 
polyacrylamide gel after completing the PCR steps. After 
electrophoresis, the poly acryl amide gel was stained with 
the silver nitrate method (Figure 4). The results of this test 
are shown in Tables 3 and 4.
Discussion
Today, the resistance of bacteria to various antibiotics 
has become a global problem due to the uncontrolled 
administration of different antibiotics for treating bacterial 
infections. Hence, resistant strains are selected dramatically 
(26-28). Resistance to antibiotic therapy in patients with 
UTIs is considered as an example of increased antimicrobial 
resistance (12). Antimicrobial resistance has always been 
a major concern for human health (6), affecting patients 
throughout the world (29). MBL encoding genes are found 
more frequently on integrins, especially Class 1 integrin, 
which has the genetic mobility of these elements and 
promotes the release of these enzymes in different parts of 
a hospital (30). Similar to studies in Columbian, Japanese, 
and Italian hospitals, VIM and IMP were observed without 
the use of carbapenem antibiotics, which confirms the 
Table 1. Primers Used for VIM and IMP by PCR
Primer Sequence (5' to 3') Size (bp)
VIM-1F TGGTTGTATACGTCCCGTCA
VIM-1 R TGTGTGCTGGAGCAAGTCTA
206
IMP-1 F TAACGGGTGGGGCGTTGTTCCT
IMP-1 R CGCCCGTGCTGTCGCTATGAAA
179
Note. VIM: Verona integron-encoded metallo-β-lactamase; IMP: imipenemase; 
PCR: polymerase chain reaction. 
Table 2. Results of phenotypic tests for the detection of MBL enzymes
Isolates (N) Disk-difiusion E-Test MHT EDS Test AmpC Disk Test
80 21 (26.25%) 21 (26.25%) 15 (18.75%) 15 (18.75%) 8 (10%)
Note. MBL: metallo-beta-lactamase; E-test: Epsilon test; MHT: modified Hodge test; EDS:  EDTA disk synergy test. 
Figure  1. Modified Hodge test. E. coli ATCC25922 causes leaf 
clover halo in the inhibition zone around meropenem as a negative 
control by the Metallo-beta-lactamase enzyme production. A is the 
positive control strain of Klebsiella pneumonia (ATCC BAA-1705). 
In addition, D and B are positive E. coli strains and C is the negative 
isolate.
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transfer of these genes between different species of bacteria 
(31,32). In this study, the prevalence of resistance to 
meropenem and imipenem in E. coli strains was 26%. In 
a study by Sahin et al, the production of MBL enzymes 
in 43 isolates of E. coli and Klebsiella (collected from 
various parts of the hospital) was evaluated during which 
35 strains were carbapenem-resistant and produced MBL 
enzymes (33). The Center for Disease Control has supplied 
the MHT for MBL-producing Enterobacteriaceae isolates 
in order to detect MBL enzymes. Although this test has a 
high potential for detecting carbapenemase enzymes, the 
results are sometimes false positive by CTX-M and AmpC 
due to the partial hydrolysis of the carbapenemse (34). In 
the MHT, the results are more reliable when used with the 
imipenem disk with 0.5 molar EDTA or 50 mM ZNSO4 
(35). The results of previous studies showed that MHT has 
less positive outcomes compared to the other tests, ranging 
from 14.8% to 51.16% (35-37), which is consistent with 
our results. In this study, 21 and 15 isolates of E. coli were 
positive by E-test and MHT method, respectively. In the 
research by Kumar et al, 28 isolates resistant of E. coli to 
meropenem (carbapenem) were reported and 6 isolates were 
positive by the MHT test, which indicates the low accuracy 
of MHT in detecting MBL strains (38). In addition, Sahin 
et al studied 43 strains of Klebsiella and E. coli and found 
that 35 strains were positive for the MHT, which were not 
reported in any of the VIM and IMP genes after the PCR 
(33). In this study, 15 isolates were positive in producing 
MBLs by the EDS test. Further, Kanchanadevi and Sekaran 
concluded that between 76 isolates of E. coli, 25 were 
resistant to imipenem using the E-test and 12 isolates were 
carbapenemase producing by the EDS test (39). AmpC is 
a cephalosporinase enzyme that leads to the hydrolysis of 
cefamycins (cefoxitin and cefotetan), which is a component 
of broad-spectrum beta-lactamase. To detect the AmpC 
beta-lactamase enzyme, AmpC disk testing can routinely 
be used in clinical laboratories. These laboratories have 
difficulty to appropriately detect this enzyme and there 
is little knowledge about the importance of this enzyme, 
which has led to the outbreak of these bacterial strains and 
even to treatment failure. In a study conducted in India, 
this enzyme was present in hospitalized strains, which 
 
EDTA disk 
Figure  2. Ethylenediaminetetraacetic acid (EDTA) disk synergy test. 
At plate 2, increasing the diameter of the inhibition zone around the 
disk containing EDTA (blank) and between two discs of meropenem 
(right) and blank  (left) represents Metallo-beta-lactamase production 
by bacteria in the presence of EDTA, inhibits the production of 
enzymes, and increases the diameter of the halo between the two 
disks.
Figure 3. AmpC disk test. The notches on the side of the disk 
represent AmpC ß-lactamase producing E. coli, which prevented the 
creation of a complete halation around the cefoxitin disk by E. coli 
ATCC 25922.
Figure 4. Colored gel of polyacrylamide. Column A: Ladder bp; B: 
Negative Control; C: Positive control of Verona integron-encoded 
Metallo-β-lactamase (VIM) gene  (P. aeruginosa PO510); D: Positive 
control of imipenemase (IMP) gene (A. baumannii AC54 / 97); E, 
F, and G columns of VIM gene and internal control gene 16srRNA 
without IMP.
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was more common in the Acinetobacter spp. Further, the 
prevalence was 6.97% for E. coli (39, 40). In our research, 
8 isolates produced AmpC beta-lactamase among E. coli 
isolates, which is consistent with the results of the study of 
Koshesh et al in Kerman. In total, 2% AmpC β-lactamase 
was positive among the 105 samples of E. coli isolated from 
UTI (41).
The presence of VIM and IMP genes with PCR was 
also evaluated in our study. The frequency of the VIM 
gene in E. coli isolates was 23.75% and the IMP gene 
was not found in E. coli strains. Based on the reports of 
Mosavian and  Koraei, the frequency of the IMP gene in 
the strains of Klebsiella, E. coli, and Enterobacter was zero 
(42). In the study conducted by Tawfik et al, 15 strains 
of MBL-producing bacteria were reported by phenotypic 
methods. All the strains were VIM positive, but the IMP 
gene was not found in any of these strains. The results of 
the above-mentioned studies are in line with those of our 
study, showing a low prevalence of IMP genes in E. coli 
(43). Furthermore, Zeighami et al evaluated the molecular 
prevalence of VIM and IMP genes among 100 isolates and 
found that the prevalence was 41% and zero for Klebsiella 
and E. coli samples, respectively, indicating the different 
outbreaks of these genes in bacteria and regions (44). 
Similarly, Mushi et al investigated 227 bacterial samples 
including Klebsiella, E. coli, and Pseudomonas aeruginosa. 
After PCR, the highest frequency was attributed to IMP 
and VIM genes with 49 and 28 cases of IMP and VIM, 
respectively, which is also consistent with our study results 
representing a lower abundance of VIM and IMP genes in 
E. coli compared to the other bacteria (45).
Conclusion
Due to the failure of antibiotic treatment and increased 
therapeutic charges, especially in UTIs, all microbiology 
laboratories should now be able to identify MBLs-
producing bacteria. In the absence of new antibiotics 
for treating infections caused by Gram-negative bacteria 
resistant to several antibiotics, the carbapenem will be 
ineffective in the near future. In addition, the treatment 
failure of these infections is predictable since these 
antibiotics are the preferred drug in treating multi-drug 
resistant bacteria. Resistance to carbapenem antibiotics is 
a growing problem and they might be replaced by novel 
antibiotics in the near future. Eventually, to control the 
emission of MBL-producing strains and the resistance of 
these microorganisms, it is necessary to come up with an 
appropriate treatment for these patients. 
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